20.01.2013 Views

PCT/1998/22 - World Intellectual Property Organization

PCT/1998/22 - World Intellectual Property Organization

PCT/1998/22 - World Intellectual Property Organization

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>22</strong>/<strong>1998</strong><br />

4 Jun/juin <strong>1998</strong> <strong>PCT</strong> Gazette - Section I - Gazette du <strong>PCT</strong> 9755<br />

(81) AU CA CN CZ HU ID IL KR MX NO NZ RU US;<br />

EP(ATBECHDEDKESFIFRGBGRIEIT<br />

LU MC NL PT SE).<br />

(11) WO 98/23272<br />

(21) <strong>PCT</strong>/US97/21152<br />

(13) A1<br />

(<strong>22</strong>) 19 Nov/nov 1997 (19.11.1997)<br />

(25) en (26) en<br />

(31) 08/753,661 (32) 27 Nov/nov 1996<br />

(27.11.1996)<br />

(33) US<br />

(43) 4 Jun/juin <strong>1998</strong> (04.06.<strong>1998</strong>)<br />

(51) 6 A61K 31/44, 33/06, 33/10, 31/715<br />

(54) COMPOSITIONS AND METHODS FOR THE<br />

TREATMENT OF<br />

DISORDERS<br />

COMPOSITIONS ET<br />

TRAITEMENT DE<br />

INTESTINAUX<br />

GASTROINTESTINAL<br />

PROCEDES POUR LE<br />

TROUBLES GASTRO–<br />

(71) THE PROCTER & GAMBLE COMPANY<br />

[US/US]; One Procter & Gamble Plaza, Cincinnati,<br />

OH 45202 (US).<br />

(72) MITRA, Sekhar; 7305 Demar Road, Cincinnati,<br />

OH 45243 (US).<br />

(74) REED, T., David et al. / etc.; The Procter &<br />

Gamble Company, 5299 Spring Grove Avenue,<br />

Cincinnati, OH 45217 (US).<br />

(81) AL AM AT AU AZ BA BB BG BR BY CA CH<br />

CN CU CZ DE DK EE ES FI GB GE GH HU ID<br />

IL IS JP KE KG KP KR KZ LC LK LR LS LT LU<br />

LV MD MG MK MN MW MX NO NZ PL PT RO<br />

RU SD SE SG SI SK SL TJ TM TR TT UA UG<br />

UZ VN YU ZW; AP (GH KE LS MW SD SZ UG<br />

ZW); EA (AM AZ BY KG KZ MD RU TJ TM);<br />

EP(ATBECHDEDKESFIFRGBGRIEIT<br />

LU MC NL PT SE); OA (BF BJ CF CG CI CM<br />

GA GN ML MR NE SN TD TG).<br />

Published / Publiée : (c)<br />

(11) WO 98/23273 (13) A1<br />

(21) <strong>PCT</strong>/US97/21136<br />

(<strong>22</strong>) 18 Nov/nov 1997 (18.11.1997)<br />

(25) en (26) en<br />

(31) 60/031,105 (32) 26 Nov/nov 1996 (33) US<br />

(26.11.1996)<br />

(43) 4 Jun/juin <strong>1998</strong> (04.06.<strong>1998</strong>)<br />

(51) 6 A61K 31/47, C07D 215/18, 215/20, 215/38,<br />

215/40<br />

(54) 4–ARYL–3–HYDROXYQUINOLIN–2–ONE DE-<br />

RIVATIVES AS ION CHANNEL MODULATORS<br />

DERIVES DE 4–ARYL–3–<br />

HYDROXYQUINOLIN–2–ONE<br />

UTILISES EN QUALITE DE MODULATEURS<br />

DE CANAL IONIQUE<br />

(71) BRISTOL–MYERS SQUIBB COMPANY [–<br />

/US]; 5 Research Parkway, Wallingford, CT<br />

06492–7660 (US).<br />

(72) SIT, Sing–Yuen; <strong>22</strong>9 Catherine Drive, Meriden,<br />

CT 06450 (US). MEANWELL, Nicholas, A.; 2<br />

Spice Hill Drive, East Hampton, CT 06424 (US).<br />

(74) ALGIERI, Aldo, A.; Bristol–Myers Squibb Company,<br />

5 Research Parkway, Wallingford, CT<br />

06492–7660 (US).<br />

(81) AL AM AT AU AZ BA BB BG BR BY CA CH<br />

CN CU CZ DE DK EE ES FI GB GE GH HU IL<br />

IS JP KE KG KP KR KZ LC LK LR LS LT LU<br />

LV MD MG MK MN MW MX NO NZ PL PT RO<br />

RU SD SE SG SI SK SL TJ TM TR TT UA UG<br />

UZ VN YU ZW; AP (GH KE LS MW SD SZ UG<br />

ZW); EA (AM AZ BY KG KZ MD RU TJ TM);<br />

EP(ATBECHDEDKESFIFRGBGRIEIT<br />

LU MC NL PT SE); OA (BF BJ CF CG CI CM<br />

GA GN ML MR NE SN TD TG).<br />

(11) WO 98/23274 (13) A1<br />

(21) <strong>PCT</strong>/US97/21306<br />

(<strong>22</strong>) 21 Nov/nov 1997 (21.11.1997)<br />

(25) en (26) en<br />

(31) 60/031,734 (32) 25 Nov/nov 1996 (33) US<br />

(25.11.1996)<br />

(31) 60/032,341 (32) 4 Dec/déc 1996 (33) US<br />

(04.12.1996)<br />

(31) 9700697.7 (32) 15 Jan/jan 1997 (33) GB<br />

(15.01.1997)<br />

(43) 4 Jun/juin <strong>1998</strong> (04.06.<strong>1998</strong>)<br />

(51) 6 A61K 31/56, 31/66<br />

(54) ANDROGENIC AND BISPHOSPHONIC<br />

AGENTS COADMINISTERED TO TREAT<br />

DISEASES<br />

AGENTS ANDROGENE ET BISPHOSPHO-<br />

NIQUE COADMINISTRES POUR TRAITER<br />

DES MALADIES<br />

(71) MERCK & CO., INC. [US/US]; 126 East Lincoln<br />

Avenue, Rahway, NJ 07065 (US).<br />

(for all designated States except / pour tous les États<br />

désignés sauf US)<br />

(72, 75) SCHMIDT, Azriel [US/US]; 126 East Lincoln<br />

Avenue, Rahway, NJ 07065 (US). RODAN, Gideon<br />

[US/US]; 126 East Lincoln Avenue, Rahway,<br />

NJ 07065 (US). HARADA, Shun–Ichi [JP/US];<br />

126 East Lincoln Avenue, Rahway, NJ 07065 (US).<br />

(74) MERCK & CO., INC.; 126 East Lincoln Avenue,<br />

Rahway, NJ 07065 (US).<br />

(81) AL AM AU AZ BA BB BG BR BY CA CN CU<br />

CZ EE GE HU ID IL IS JP KG KR KZ LC LK LR<br />

LT LV MD MG MK MN MX NO NZ PL RO RU<br />

SG SI SK SL TJ TM TR TT UA US UZ VN YU;<br />

AP (GH KE LS MW SD SZ UG ZW); EA (AM<br />

AZ BY KG KZ MD RU TJ TM); EP (AT BE CH<br />

DE DK ES FI FR GB GR IE IT LU MC NL PT<br />

SE); OA (BF BJ CF CG CI CM GA GN ML MR<br />

NE SN TD TG).<br />

(11) WO 98/23275 (13) A1<br />

(21) <strong>PCT</strong>/EP97/06447<br />

(<strong>22</strong>) 19 Nov/nov 1997 (19.11.1997)<br />

(25) de (26) de<br />

(31) 196 49 286.6 (32) 28 Nov/nov 1996 (33) DE<br />

(28.11.1996)<br />

(31) 197 00 796.1 (32) 13 Jan/jan 1997 (33) DE<br />

(13.01.1997)<br />

(43) 4 Jun/juin <strong>1998</strong> (04.06.<strong>1998</strong>)<br />

(51) 6 A61K 31/575 // (A61K 31/575, 31:355)<br />

(54) USE OF MIXTURES OF ACTIVE SUBSTANCES<br />

FOR THE PRODUCTION OF HYPOCHOLESTE-<br />

REMIC AGENTS<br />

UTILISATION DE MELANGES DE PRINCIPES<br />

ACTIFS POUR LA PRODUCTION D’AGENTS<br />

HYPOCHOLESTEROLEMIANTS<br />

(71) HENKEL KOMMANDITGESELLSCHAFT<br />

AUF AKTIEN [DE/DE]; Henkelstrasse 67,<br />

D–40589 Düsseldorf (DE).<br />

(for all designated States except / pour tous les États<br />

désignés sauf US)<br />

(72, 75) WEITKEMPER, Norbert [DE/DE];<br />

Sürderstrasse 57, D–51375 Leverkusen (DE).<br />

FABRY, Bernd [DE/DE]; Danziger Strasse 31,<br />

D–41352 Korschenbroich (DE).<br />

(81) AU BR CA CN CZ HU JP KR MX NO NZ PL RU<br />

SI SK US; EP (AT BE CH DE DK ES FI FR GB<br />

GR IE IT LU MC NL PT SE).<br />

Published / Publiée : (c)<br />

(11) WO 98/23276 (13) A2<br />

(21) <strong>PCT</strong>/BG97/00013<br />

(<strong>22</strong>) 14 Nov/nov 1997 (14.11.1997)<br />

(25) en (26) en<br />

(31) 101011 (32) 25 Nov/nov 1996<br />

(25.11.1996)<br />

(43) 4 Jun/juin <strong>1998</strong> (04.06.<strong>1998</strong>)<br />

(33) BG<br />

(51) 6 A61K 31/70, 33/00, 9/127 // (A61K 31/70, 33:00)<br />

(54) LIPOSOMES COMPRISING AZIDOTHY-<br />

MIDINE AND LITHIUM FOR TREATING<br />

HIV/AIDS<br />

LIPOSOMES, RENFERMANT DE LA ZIDO-<br />

VUDINE ET DU LITHIUM, AUX FINS DU<br />

TRAITEMENT DU SYNDROME D’IMMUNO–<br />

DEFICIENCE ACQUISE DECLENCHE PAR<br />

LE VIRUS DE L’IMMUNO–DEFICIENCE HU-<br />

MAINE (SIDA/VIH)<br />

(71) ANRET LTD. [BG/BG]; Dragan Tsankov Boulevard,<br />

Bl.59–63, Entr.Be, fl.2, Ap.4, 1172 Sofia<br />

(BG).<br />

(for all designated States except / pour tous les États<br />

désignés sauf US)<br />

(72, 75) GABEV, Evgeni Bogomilov [BG/BG];<br />

Acad.Metody Popov Street 10, Bl.63, 1113 Sofia<br />

(BG). GABEV, Evgeni Evgeniev [BG/BG];<br />

kv.Dianabad, Bl.41, fl.11, Ap.55, 1172 Sofia (BG).<br />

(74) HRISTOVA, Lilyana Lyubomirova; Gatev &<br />

Shentova Patent Bureau, Damyan Gruev Street 11,<br />

1606 Sofia (BG).<br />

(81) AL AM AT AU AZ BA BB BG BR BY CA CH<br />

CN CU CZ DE DK EE ES FI GB GE GH HU IL<br />

IS JP KE KG KP KR KZ LC LK LR LS LT LU<br />

LV MD MG MK MN MW MX NO NZ PL PT RO<br />

RU SD SE SG SI SK SL TJ TM TR TT UA UG<br />

US UZ VN YU ZW; AP (GH KE LS MW SD SZ<br />

UG ZW); EA (AM AZ BY KG KZ MD RU TJ<br />

TM); EP (AT BE CH DE DK ES FI FR GB GR<br />

IE IT LU MC NL PT SE); OA (BF BJ CF CG CI<br />

CM GA GN ML MR NE SN TD TG).<br />

(11) WO 98/23277 (13) A1<br />

(21) <strong>PCT</strong>/EP97/06450<br />

(<strong>22</strong>) 19 Nov/nov 1997 (19.11.1997)<br />

(25) de (26) de<br />

(31) 196 49 286.6 (32) 28 Nov/nov 1996<br />

(28.11.1996)<br />

(31) 197 00 796.1 (32) 13 Jan/jan 1997<br />

(13.01.1997)<br />

(43) 4 Jun/juin <strong>1998</strong> (04.06.<strong>1998</strong>)<br />

(51) 6 A61K 31/70, 31/73, 31/575<br />

(33) DE<br />

(33) DE<br />

(54) USE OF MIXTURES OF ACTIVE SUB-<br />

STANCES, CONTAINING PHYTOSTENOLS<br />

AND/OR PHYTOSTENOL ESTERS AND PO-<br />

TENTIATORS, FOR THE PRODUCTION OF<br />

HYPOCHOLESTEREMIC AGENTS<br />

UTILISATION DE MELANGES DE PRINCIPES<br />

ACTIFS, CONTENANT DES PHYTOSTENOLS<br />

ET/OU DES ESTERS DE PHYTOSTENOL ET<br />

DES AGENTS DE POTENTIALISATION, POUR<br />

LA PRODUCTION D’AGENTS HYPOCHOLES-<br />

TEROLEMIANTS<br />

(71) HENKEL KOMMANDITGESELLSCHAFT<br />

AUF AKTIEN [DE/DE]; Henkelstrasse 67,<br />

D–40589 Düsseldorf (DE).<br />

(for all designated States except / pour tous les États<br />

désignés sauf US)<br />

(72, 75) WEITKEMPER, Norbert [DE/DE];<br />

Sürderstrasse 57, D–51375 Leverkusen (DE).<br />

FABRY, Bernd [DE/DE]; Danziger Strasse 31,<br />

D–41352 Korschenbroich (DE).

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!